Sign in

NCT05617742Completed

Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

68Ga-FAPI PET in Evaluation of the Patient With Known or Suspected Lung Cancer: Comparison With Standard 18F-FDG PET

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

This is a prospective, single-center, single arm, open label study to evaluate the performance of 68Ga-FAPI-46 for the diagnosis of primary and metastatic lesions of lung cancer with comparison to 18F-FDG PET.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
8 Nov 2022
Start date
1 Dec 2022
Primary completion date
31 Jan 2026
Lead sponsor
Chang Gung Memorial Hospital
Diseases
Lung cancer
NCT number
NCT05617742

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 1 Dec 2022 to the primary completion date, 31 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Undergoing irradiation at accrual

Other illness

  • Patients with mainly malignant pleural effusion without other measurable lesions
  • Active infection or other serious underlying medical conditions not compatible with study entry
  • History of significant neurological or psychiatric disorders including dementia that would prohibit the understanding and giving of informed consent

Other

  • Contraindication to FAPI-PET and FDG-PET such as pregnant, or lactating patients

Who the study is looking for

  • Age \> 20 years
  • Informed consent obtained from patients and families
  • Patients with histology confirmed lung cancer or patients with GGO on chest CT planned to have biopsy or surgery
  • Patients scheduled to undergo FDG-PET examination
  • Performance status: 0, 1, 2, 3

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Department of Nuclear Medicine, Chang Gung Memorial Hospital
Coordinator of this site? Confirm its status
TaoyuanTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.